SlideShare a Scribd company logo
1 of 34
Managing pain in the older person
Linda Nazarko
Consultant Nurse London North West
Healthcare NHS Trust
22nd
September 2015
Aims and objectives
To be aware of:
 The prevalence of pain in older people
 Types of pain experienced
 How to determine treatment options
 How to assess pain in older people
 The effects of aging and comorbidities
 Drug interactions
 How to work with the older person to
identify and manage side effects
 How to improve concordance
What is pain?
 “An unpleasant
sensory or emotional
experience
associated with actual
or potential tissue
damage or described
in terms of such
damage”
 (IASP, 1994)
Prevalence
 Increases with
age
 Affects 53% older
people
 Affects ability,
mobility, mood,
sleep, quality of
life
Musculoskeletal Pain
 “Pain perceived within a
region of the body, and
believed to arise from the
muscles, ligaments, bones,
or joints” (IASP, 2009).
 Tender, aching, stiff,
throbbing
 Causes include:
Fibromyalgia, gout,
osteoarthritis, rheumatoid
arthritis, tendinitis
Neuropathic pain
 “Pain arising as a direct consequence
of a lesion or disease affecting the
somatosensory system either at
peripheral or central level” (Haanpää
et al, 2011).
 Shooting and burning, tingling &
numbness, stabbing, electric shock
like.
 Alcoholism,amputation, back, leg, &
hip problems, chemotherapy,
diabetes, facial nerve problems,HIV
infection or AIDS, Multiple sclerosis,
shingles, spinal surgery
Visceral: Pain arising from internal organs
 “True visceral pain’ arises as a diffuse
and poorly defined sensation usually
perceived in the midline of the body, at
the lower sternum or upper
abdomen”( Procacci et al, 1986).
 Poorly localised, nonspecific regional
or whole-body motor responses, strong
autonomic & affective responses.
 Appendicitis, bowel obstruction, cancer
pain, dysmenorrhea, indigestion,
irritable bowel syndrome, renal colic,
urinary retention
Differentiating neuropathic & muscle
pain
(Nazarko, 2014)
Determining treatment options
Be aware that not everyone likes to complain
Be alert to non verbal signs
Enquire about pain
Detailed clinical assessment of causes, types
Be alert to sensory & cognitive impairment
Eyesight
 20% of people aged over 75 and
50% of people aged 90 and over
have sight loss (Access
Economics, 2009). Be as visible
as possible
 Ensure lighting is good
 Some older people with impaired
hearing lip read so ensure they
can see your face and mouth
 Be receptive
Hearing
More than 70% of over 70
year-olds and 40% of over 50
year-olds have some form of
hearing loss (Action on Hearing Loss, 2011)
Minimise noise, be visible,
don’t cover your mouth
Speak clearly and slow down
slightly
Check that you have been
understood
Dementia
 Be aware that the incidence of
dementia rises with age and
around 25% of 85 year olds and
50% of 90 year olds have
dementia (Knapp & Prince, 2007).
 Ensure that you have picked a
time when the person is
receptive.
 Take account of any cognitive or
sensory difficulties
The value of nursing
"Nursing is rooted from the needs of humanity
and is founded on the ideal of service. And
that, “the nurse is temporarily the
consciousness of the unconscious, the
love of life for the suicidal, the leg of the
amputee, the eyes of the newly blind, a
means of locomotion for the infant,
knowledge and confidence for the mother
and the mouthpiece for those too weak or
withdrawn to speak”
“Only when I move” syndrome
 Be aware of the need to
check that even though
the person doesn’t have
pain now they might have
when they are active.
“Ten” syndrome
 This is when a person
consistently rates pain at
10 even though staff
observe that it seems to
vary.
“Mustn’t grumble” syndrome
 Be aware of those
who don’t like to
complain or who fear
side effects of
analgesia
Use the right tools
 Pictures, body maps, Abbey pain scale
 Evaluate regularly
Age related chages
 Age related changes cause reduced ability to absorb and
excrete drugs (Wooten, 2012: Miller, 2007: Miller, 2000: Nguyen & Goldfarb, 2012: Esposito et al,
2007: Mühlberg & Platt, 1999).
 >Gastrointestinal motility and >gastro-intestinal blood flow
 Changes in distribution of drugs due to > in muscle mass
& < in fat
 > ability to metabolise drugs due to > hepatic blood flow &
liver mass
 Reduced ability to excrete drugs due to decline in renal
function
 Changes at molecular level that alter receptor binding and
may < or > sensitivity to particular classes of drugs.
Comorbidities
 Cardiac failure- 12-13% over 75s
 CKD -33% over 75s
 Gastro-intestinal disease, peptic ulcers, oesophageal
varices, diverticular disease
 Asthma- 10% over 65s
 Dysphagia – 11% upwards
 Dementia 25% at 85 and 50% at 90
How comorbidities affect treatment
 Cardiac failure -NSAIDs > oedema, worsen
failure – contraindicated
 Renal failure- NSAIDS nephrotoxic, opiates
and codeine with great caution
 Dysphagia- soluble meds > Na, BP and
stroke risk
 Dementia, tramadol, codeine, opiates, > falls
risk
 Depression – anti-depressants + tramadol =
seratonin syndrome
Drug interactions
 Remember falls risk
 “Sedatives, analgesics and anti-
depressants dangerous
 Opiods double risk injurious falls
 Non opiods can > risk by 15-75%
 Tramadol and anti-depressants
 High doses, small people, > metabolism
Concordance
 40% non concordant
why?
 Side effects
 Worried addition
 Difficulty swallowing
 Forgetting to take
 Unsure of then to take
 How many pills
prepared to take
Identify and manage side effects
 Explain possible side
effects
 Discuss, be partners and
negotiate
 Work out if its worth
managing side effects or
changing tack
 Have a dialogue
Treating pain
1. “By mouth":
2. “By the Clock”
3. “Around the clock
4. "By the Ladder":
5. For the individual
Treating pain
Codeine metabolism
 CYP2D6 responsible codeine
metabolism
 Genetic differences, slow and fast
metabolisers
 Ineffective in slow metabolisers
 Fast metabolisers at risk of toxicity
Be alert to differences and use clinical
judgement to guide treatment.
Prevalence rates of CYP2D6
polymorphisms by ethnicity
Ethnicity Slow metabolisers Ultra-fast metabolisers
Western European 8–10% 1–4%
Southern European 7–10%
African 0–20% 5–30%
Eastern Asian 0–1%
Arabian Up to 20%
Tramadol
 Tramadol centrally acting synthetic analgesic
compound (EMC, 2014).
 Tramadol 100 mg = paracetamol & codeine (1000
mg/60 mg) (Kaye, 2004).
 Risk factor post operative delirium (Künig et al,
2006)
 Increases falls risk X10 )Costa-Dias et al,2014)
 Increased risk falls, #, mortality (Gogol et al, 2014)
Use tramadol with extreme caution in older
people.
NSAIDS
 17 million NSAID prescriptions are
issued in the UK each year
 Can improve quality of life but treatment
can be risky
 Co-prescription of NSAIDs, diuretics
and ACE inhibitors = > renal perfusion<
renal dysfunction
NSAIDS (2)
 Worsen heart failure contraindicated
severe failure
 Contraindicated asthma
 Increased risk heart attack, heart failure
 Nephrotoxic
 Naproxen lower cardiac risk, higher
bleeding risk
 Use NSAIDS only after careful
evaluation of individual risk
Opiates
 Hazardous in older people
 Increased risk toxicity due to renal and
hepatic changes
 Start at doses 25-50% lower than in
younger adults
Monitor with great care
Last words
 Assess to work out
what the problems
are and how to treat
 Its not a pill for every
ill
 Therapy and non
drug options
 Sometimes a poodle
is better than a pain
killer
Thank you for listening
Any questions?

More Related Content

Viewers also liked

Photography Pictures by Joshua Powers
Photography Pictures by Joshua PowersPhotography Pictures by Joshua Powers
Photography Pictures by Joshua PowersJoshua Powers
 
Abstract Managing_pain_in_the_older_person
Abstract  Managing_pain_in_the_older_personAbstract  Managing_pain_in_the_older_person
Abstract Managing_pain_in_the_older_personLinda Nazarko
 
Bachelors Degree in Multimedia Design and Development
Bachelors Degree in Multimedia Design and DevelopmentBachelors Degree in Multimedia Design and Development
Bachelors Degree in Multimedia Design and DevelopmentJoshua Powers
 
Отчет ДО ГБОУ СОШ №1985 (Группа №3) март-май 2015 г.
Отчет ДО ГБОУ СОШ №1985 (Группа №3)  март-май 2015 г.Отчет ДО ГБОУ СОШ №1985 (Группа №3)  март-май 2015 г.
Отчет ДО ГБОУ СОШ №1985 (Группа №3) март-май 2015 г.GBOU_SOSH
 
Отчёт ДО ГБОУ СОШ №1985 (Группа №2) март-май, 2015 г.
Отчёт ДО ГБОУ СОШ №1985 (Группа №2) март-май, 2015 г.Отчёт ДО ГБОУ СОШ №1985 (Группа №2) март-май, 2015 г.
Отчёт ДО ГБОУ СОШ №1985 (Группа №2) март-май, 2015 г.GBOU_SOSH
 
21st corp outline webinar (3)
21st corp outline webinar (3)21st corp outline webinar (3)
21st corp outline webinar (3)Kerry Morgan
 
Applied motion products 3540i datasheet
Applied motion products 3540i datasheetApplied motion products 3540i datasheet
Applied motion products 3540i datasheetElectromate
 
Advanced Health And Nutrition Webinar
Advanced Health And Nutrition WebinarAdvanced Health And Nutrition Webinar
Advanced Health And Nutrition WebinarNickalas D'Urso
 
Applied motion products 2035 datasheet
Applied motion products 2035 datasheetApplied motion products 2035 datasheet
Applied motion products 2035 datasheetElectromate
 
November 2016 Nursing clinics. Essential characteristics nurse clinics and s...
November 2016 Nursing clinics.  Essential characteristics nurse clinics and s...November 2016 Nursing clinics.  Essential characteristics nurse clinics and s...
November 2016 Nursing clinics. Essential characteristics nurse clinics and s...Linda Nazarko
 
Curso de Microbiología - 06 - Genética y Resistencia Microbiana
Curso de Microbiología - 06 -  Genética y Resistencia MicrobianaCurso de Microbiología - 06 -  Genética y Resistencia Microbiana
Curso de Microbiología - 06 - Genética y Resistencia MicrobianaAntonio E. Serrano
 
Welfare Aziendale Rassegna Stampa Welfare Company
Welfare Aziendale Rassegna Stampa Welfare CompanyWelfare Aziendale Rassegna Stampa Welfare Company
Welfare Aziendale Rassegna Stampa Welfare Companywelfarecompany
 
Social gaming - Il gioco diventa business
Social gaming - Il gioco diventa businessSocial gaming - Il gioco diventa business
Social gaming - Il gioco diventa businessSalvatore Vicinzino
 

Viewers also liked (19)

Photography Pictures by Joshua Powers
Photography Pictures by Joshua PowersPhotography Pictures by Joshua Powers
Photography Pictures by Joshua Powers
 
Test worpress
Test worpressTest worpress
Test worpress
 
OPAT April 2016
OPAT April 2016OPAT April 2016
OPAT April 2016
 
Abstract Managing_pain_in_the_older_person
Abstract  Managing_pain_in_the_older_personAbstract  Managing_pain_in_the_older_person
Abstract Managing_pain_in_the_older_person
 
Bachelors Degree in Multimedia Design and Development
Bachelors Degree in Multimedia Design and DevelopmentBachelors Degree in Multimedia Design and Development
Bachelors Degree in Multimedia Design and Development
 
Отчет ДО ГБОУ СОШ №1985 (Группа №3) март-май 2015 г.
Отчет ДО ГБОУ СОШ №1985 (Группа №3)  март-май 2015 г.Отчет ДО ГБОУ СОШ №1985 (Группа №3)  март-май 2015 г.
Отчет ДО ГБОУ СОШ №1985 (Группа №3) март-май 2015 г.
 
Отчёт ДО ГБОУ СОШ №1985 (Группа №2) март-май, 2015 г.
Отчёт ДО ГБОУ СОШ №1985 (Группа №2) март-май, 2015 г.Отчёт ДО ГБОУ СОШ №1985 (Группа №2) март-май, 2015 г.
Отчёт ДО ГБОУ СОШ №1985 (Группа №2) март-май, 2015 г.
 
21st corp outline webinar (3)
21st corp outline webinar (3)21st corp outline webinar (3)
21st corp outline webinar (3)
 
Managing medication
Managing medicationManaging medication
Managing medication
 
Ppt herramientas web sdl
Ppt herramientas web sdlPpt herramientas web sdl
Ppt herramientas web sdl
 
CU Boulder Classes
CU Boulder ClassesCU Boulder Classes
CU Boulder Classes
 
Applied motion products 3540i datasheet
Applied motion products 3540i datasheetApplied motion products 3540i datasheet
Applied motion products 3540i datasheet
 
Advanced Health And Nutrition Webinar
Advanced Health And Nutrition WebinarAdvanced Health And Nutrition Webinar
Advanced Health And Nutrition Webinar
 
Applied motion products 2035 datasheet
Applied motion products 2035 datasheetApplied motion products 2035 datasheet
Applied motion products 2035 datasheet
 
November 2016 Nursing clinics. Essential characteristics nurse clinics and s...
November 2016 Nursing clinics.  Essential characteristics nurse clinics and s...November 2016 Nursing clinics.  Essential characteristics nurse clinics and s...
November 2016 Nursing clinics. Essential characteristics nurse clinics and s...
 
LSBU C Diff 2016
LSBU C Diff 2016LSBU C Diff 2016
LSBU C Diff 2016
 
Curso de Microbiología - 06 - Genética y Resistencia Microbiana
Curso de Microbiología - 06 -  Genética y Resistencia MicrobianaCurso de Microbiología - 06 -  Genética y Resistencia Microbiana
Curso de Microbiología - 06 - Genética y Resistencia Microbiana
 
Welfare Aziendale Rassegna Stampa Welfare Company
Welfare Aziendale Rassegna Stampa Welfare CompanyWelfare Aziendale Rassegna Stampa Welfare Company
Welfare Aziendale Rassegna Stampa Welfare Company
 
Social gaming - Il gioco diventa business
Social gaming - Il gioco diventa businessSocial gaming - Il gioco diventa business
Social gaming - Il gioco diventa business
 

Similar to Managing Pain in Older People

cancer pain management
cancer pain managementcancer pain management
cancer pain managementGowri Shankar
 
Geriatric health with their problem and control
Geriatric health with their problem and controlGeriatric health with their problem and control
Geriatric health with their problem and controlDhruvendra Pandey
 
Uncovering Pain: The physiological and psychological components of pain
Uncovering Pain:  The physiological and psychological components of painUncovering Pain:  The physiological and psychological components of pain
Uncovering Pain: The physiological and psychological components of painErik Nason MBA, MS, ATC, LAT, CSCS
 
Peripheral Neuropathy: Will it ever go away? Problems, Causes, Solutions
Peripheral Neuropathy: Will it ever go away? Problems, Causes, SolutionsPeripheral Neuropathy: Will it ever go away? Problems, Causes, Solutions
Peripheral Neuropathy: Will it ever go away? Problems, Causes, SolutionsFight Colorectal Cancer
 
Geriatric care & problems.pptx
Geriatric care & problems.pptxGeriatric care & problems.pptx
Geriatric care & problems.pptxrambhapathak
 
Tony Bayer - Dementia prevention
Tony Bayer - Dementia preventionTony Bayer - Dementia prevention
Tony Bayer - Dementia preventionangewatkins
 
Health and wellness HW-7 adult hood.pptx
Health and wellness HW-7 adult hood.pptxHealth and wellness HW-7 adult hood.pptx
Health and wellness HW-7 adult hood.pptxAbdulGhayur1
 
MON 2011 - Slide 33 - A. Hoy - Advanced disease management
MON 2011 - Slide 33 - A. Hoy - Advanced disease managementMON 2011 - Slide 33 - A. Hoy - Advanced disease management
MON 2011 - Slide 33 - A. Hoy - Advanced disease managementEuropean School of Oncology
 
MCO 2011 - Slide 37 - A. Hoy - Advanced disease management
MCO 2011 - Slide 37 - A. Hoy - Advanced disease managementMCO 2011 - Slide 37 - A. Hoy - Advanced disease management
MCO 2011 - Slide 37 - A. Hoy - Advanced disease managementEuropean School of Oncology
 
Lifestyle &amp; health
Lifestyle &amp; healthLifestyle &amp; health
Lifestyle &amp; healthmonaaboserea
 
GMO Crops, Glyphosate and the deterioration of health in the USA
GMO Crops, Glyphosate and the deterioration of health in the USAGMO Crops, Glyphosate and the deterioration of health in the USA
GMO Crops, Glyphosate and the deterioration of health in the USAJack Olmsted
 
Palliative care for family medicine trainees 2015
Palliative care for family medicine trainees 2015Palliative care for family medicine trainees 2015
Palliative care for family medicine trainees 2015Chai-Eng Tan
 
Mistakes in Epilepsy Care - Orrin Devinsky, MD
Mistakes in Epilepsy Care - Orrin Devinsky, MDMistakes in Epilepsy Care - Orrin Devinsky, MD
Mistakes in Epilepsy Care - Orrin Devinsky, MDNYU FACES
 
Sleep Apnoea a walk-through
Sleep Apnoea a walk-through Sleep Apnoea a walk-through
Sleep Apnoea a walk-through MIOT Hospitals
 
癌症病人之運動處方 曹昭懿
癌症病人之運動處方 曹昭懿癌症病人之運動處方 曹昭懿
癌症病人之運動處方 曹昭懿Kit Leong
 
Palliative care with cancer patients 1
Palliative care with cancer patients 1Palliative care with cancer patients 1
Palliative care with cancer patients 1Tariq Mohammed
 

Similar to Managing Pain in Older People (20)

cancer pain management
cancer pain managementcancer pain management
cancer pain management
 
Pain in Dementia
Pain in DementiaPain in Dementia
Pain in Dementia
 
Geriatric health with their problem and control
Geriatric health with their problem and controlGeriatric health with their problem and control
Geriatric health with their problem and control
 
Cancer Pain
Cancer PainCancer Pain
Cancer Pain
 
Uncovering Pain: The physiological and psychological components of pain
Uncovering Pain:  The physiological and psychological components of painUncovering Pain:  The physiological and psychological components of pain
Uncovering Pain: The physiological and psychological components of pain
 
Peripheral Neuropathy: Will it ever go away? Problems, Causes, Solutions
Peripheral Neuropathy: Will it ever go away? Problems, Causes, SolutionsPeripheral Neuropathy: Will it ever go away? Problems, Causes, Solutions
Peripheral Neuropathy: Will it ever go away? Problems, Causes, Solutions
 
Geriatric care & problems.pptx
Geriatric care & problems.pptxGeriatric care & problems.pptx
Geriatric care & problems.pptx
 
Tony Bayer - Dementia prevention
Tony Bayer - Dementia preventionTony Bayer - Dementia prevention
Tony Bayer - Dementia prevention
 
Health and wellness HW-7 adult hood.pptx
Health and wellness HW-7 adult hood.pptxHealth and wellness HW-7 adult hood.pptx
Health and wellness HW-7 adult hood.pptx
 
MON 2011 - Slide 33 - A. Hoy - Advanced disease management
MON 2011 - Slide 33 - A. Hoy - Advanced disease managementMON 2011 - Slide 33 - A. Hoy - Advanced disease management
MON 2011 - Slide 33 - A. Hoy - Advanced disease management
 
MCO 2011 - Slide 37 - A. Hoy - Advanced disease management
MCO 2011 - Slide 37 - A. Hoy - Advanced disease managementMCO 2011 - Slide 37 - A. Hoy - Advanced disease management
MCO 2011 - Slide 37 - A. Hoy - Advanced disease management
 
Lifestyle &amp; health
Lifestyle &amp; healthLifestyle &amp; health
Lifestyle &amp; health
 
GMO Crops, Glyphosate and the deterioration of health in the USA
GMO Crops, Glyphosate and the deterioration of health in the USAGMO Crops, Glyphosate and the deterioration of health in the USA
GMO Crops, Glyphosate and the deterioration of health in the USA
 
Palliative care for family medicine trainees 2015
Palliative care for family medicine trainees 2015Palliative care for family medicine trainees 2015
Palliative care for family medicine trainees 2015
 
Sandy Coulson Sleep Disorder Spreecast
Sandy Coulson Sleep Disorder SpreecastSandy Coulson Sleep Disorder Spreecast
Sandy Coulson Sleep Disorder Spreecast
 
Mistakes in Epilepsy Care - Orrin Devinsky, MD
Mistakes in Epilepsy Care - Orrin Devinsky, MDMistakes in Epilepsy Care - Orrin Devinsky, MD
Mistakes in Epilepsy Care - Orrin Devinsky, MD
 
Cancer: Are We Losing the Fight?
Cancer:  Are We Losing the Fight? Cancer:  Are We Losing the Fight?
Cancer: Are We Losing the Fight?
 
Sleep Apnoea a walk-through
Sleep Apnoea a walk-through Sleep Apnoea a walk-through
Sleep Apnoea a walk-through
 
癌症病人之運動處方 曹昭懿
癌症病人之運動處方 曹昭懿癌症病人之運動處方 曹昭懿
癌症病人之運動處方 曹昭懿
 
Palliative care with cancer patients 1
Palliative care with cancer patients 1Palliative care with cancer patients 1
Palliative care with cancer patients 1
 

Managing Pain in Older People

  • 1. Managing pain in the older person Linda Nazarko Consultant Nurse London North West Healthcare NHS Trust 22nd September 2015
  • 2. Aims and objectives To be aware of:  The prevalence of pain in older people  Types of pain experienced  How to determine treatment options  How to assess pain in older people  The effects of aging and comorbidities  Drug interactions  How to work with the older person to identify and manage side effects  How to improve concordance
  • 3. What is pain?  “An unpleasant sensory or emotional experience associated with actual or potential tissue damage or described in terms of such damage”  (IASP, 1994)
  • 4. Prevalence  Increases with age  Affects 53% older people  Affects ability, mobility, mood, sleep, quality of life
  • 5. Musculoskeletal Pain  “Pain perceived within a region of the body, and believed to arise from the muscles, ligaments, bones, or joints” (IASP, 2009).  Tender, aching, stiff, throbbing  Causes include: Fibromyalgia, gout, osteoarthritis, rheumatoid arthritis, tendinitis
  • 6. Neuropathic pain  “Pain arising as a direct consequence of a lesion or disease affecting the somatosensory system either at peripheral or central level” (Haanpää et al, 2011).  Shooting and burning, tingling & numbness, stabbing, electric shock like.  Alcoholism,amputation, back, leg, & hip problems, chemotherapy, diabetes, facial nerve problems,HIV infection or AIDS, Multiple sclerosis, shingles, spinal surgery
  • 7. Visceral: Pain arising from internal organs  “True visceral pain’ arises as a diffuse and poorly defined sensation usually perceived in the midline of the body, at the lower sternum or upper abdomen”( Procacci et al, 1986).  Poorly localised, nonspecific regional or whole-body motor responses, strong autonomic & affective responses.  Appendicitis, bowel obstruction, cancer pain, dysmenorrhea, indigestion, irritable bowel syndrome, renal colic, urinary retention
  • 8. Differentiating neuropathic & muscle pain (Nazarko, 2014)
  • 9. Determining treatment options Be aware that not everyone likes to complain Be alert to non verbal signs Enquire about pain Detailed clinical assessment of causes, types Be alert to sensory & cognitive impairment
  • 10. Eyesight  20% of people aged over 75 and 50% of people aged 90 and over have sight loss (Access Economics, 2009). Be as visible as possible  Ensure lighting is good  Some older people with impaired hearing lip read so ensure they can see your face and mouth  Be receptive
  • 11. Hearing More than 70% of over 70 year-olds and 40% of over 50 year-olds have some form of hearing loss (Action on Hearing Loss, 2011) Minimise noise, be visible, don’t cover your mouth Speak clearly and slow down slightly Check that you have been understood
  • 12. Dementia  Be aware that the incidence of dementia rises with age and around 25% of 85 year olds and 50% of 90 year olds have dementia (Knapp & Prince, 2007).  Ensure that you have picked a time when the person is receptive.  Take account of any cognitive or sensory difficulties
  • 13. The value of nursing "Nursing is rooted from the needs of humanity and is founded on the ideal of service. And that, “the nurse is temporarily the consciousness of the unconscious, the love of life for the suicidal, the leg of the amputee, the eyes of the newly blind, a means of locomotion for the infant, knowledge and confidence for the mother and the mouthpiece for those too weak or withdrawn to speak”
  • 14. “Only when I move” syndrome  Be aware of the need to check that even though the person doesn’t have pain now they might have when they are active.
  • 15. “Ten” syndrome  This is when a person consistently rates pain at 10 even though staff observe that it seems to vary.
  • 16. “Mustn’t grumble” syndrome  Be aware of those who don’t like to complain or who fear side effects of analgesia
  • 17. Use the right tools  Pictures, body maps, Abbey pain scale  Evaluate regularly
  • 18. Age related chages  Age related changes cause reduced ability to absorb and excrete drugs (Wooten, 2012: Miller, 2007: Miller, 2000: Nguyen & Goldfarb, 2012: Esposito et al, 2007: Mühlberg & Platt, 1999).  >Gastrointestinal motility and >gastro-intestinal blood flow  Changes in distribution of drugs due to > in muscle mass & < in fat  > ability to metabolise drugs due to > hepatic blood flow & liver mass  Reduced ability to excrete drugs due to decline in renal function  Changes at molecular level that alter receptor binding and may < or > sensitivity to particular classes of drugs.
  • 19. Comorbidities  Cardiac failure- 12-13% over 75s  CKD -33% over 75s  Gastro-intestinal disease, peptic ulcers, oesophageal varices, diverticular disease  Asthma- 10% over 65s  Dysphagia – 11% upwards  Dementia 25% at 85 and 50% at 90
  • 20. How comorbidities affect treatment  Cardiac failure -NSAIDs > oedema, worsen failure – contraindicated  Renal failure- NSAIDS nephrotoxic, opiates and codeine with great caution  Dysphagia- soluble meds > Na, BP and stroke risk  Dementia, tramadol, codeine, opiates, > falls risk  Depression – anti-depressants + tramadol = seratonin syndrome
  • 21. Drug interactions  Remember falls risk  “Sedatives, analgesics and anti- depressants dangerous  Opiods double risk injurious falls  Non opiods can > risk by 15-75%  Tramadol and anti-depressants  High doses, small people, > metabolism
  • 22.
  • 23. Concordance  40% non concordant why?  Side effects  Worried addition  Difficulty swallowing  Forgetting to take  Unsure of then to take  How many pills prepared to take
  • 24. Identify and manage side effects  Explain possible side effects  Discuss, be partners and negotiate  Work out if its worth managing side effects or changing tack  Have a dialogue
  • 25. Treating pain 1. “By mouth": 2. “By the Clock” 3. “Around the clock 4. "By the Ladder": 5. For the individual
  • 27. Codeine metabolism  CYP2D6 responsible codeine metabolism  Genetic differences, slow and fast metabolisers  Ineffective in slow metabolisers  Fast metabolisers at risk of toxicity Be alert to differences and use clinical judgement to guide treatment.
  • 28. Prevalence rates of CYP2D6 polymorphisms by ethnicity Ethnicity Slow metabolisers Ultra-fast metabolisers Western European 8–10% 1–4% Southern European 7–10% African 0–20% 5–30% Eastern Asian 0–1% Arabian Up to 20%
  • 29. Tramadol  Tramadol centrally acting synthetic analgesic compound (EMC, 2014).  Tramadol 100 mg = paracetamol & codeine (1000 mg/60 mg) (Kaye, 2004).  Risk factor post operative delirium (Künig et al, 2006)  Increases falls risk X10 )Costa-Dias et al,2014)  Increased risk falls, #, mortality (Gogol et al, 2014) Use tramadol with extreme caution in older people.
  • 30. NSAIDS  17 million NSAID prescriptions are issued in the UK each year  Can improve quality of life but treatment can be risky  Co-prescription of NSAIDs, diuretics and ACE inhibitors = > renal perfusion< renal dysfunction
  • 31. NSAIDS (2)  Worsen heart failure contraindicated severe failure  Contraindicated asthma  Increased risk heart attack, heart failure  Nephrotoxic  Naproxen lower cardiac risk, higher bleeding risk  Use NSAIDS only after careful evaluation of individual risk
  • 32. Opiates  Hazardous in older people  Increased risk toxicity due to renal and hepatic changes  Start at doses 25-50% lower than in younger adults Monitor with great care
  • 33. Last words  Assess to work out what the problems are and how to treat  Its not a pill for every ill  Therapy and non drug options  Sometimes a poodle is better than a pain killer
  • 34. Thank you for listening Any questions?

Editor's Notes

  1.  
  2.  
  3. In acute and chronic non-malignant pain, Tramadol is metabolised by the liver and excreted by the kidneys so dosage should be adjusted in older people and those with impaired renal and liver function (Kaye, 2004: EMC, 2014). Older people may be at greater risk of adverse effects from Tramadol than younger people. Brouquet and colleagues (2010) discuss how administration of tramadol is one of the risk factors for post-operative delirium in older people. work describes long lasting tramadol induced delirium. They comment   “Although tramadol may represent a well established safe therapy for chronic non-malignant pain in the elderly, these cases demonstrate that it should be applied with caution even in healthy subjects”   There is growing evidence of a high correlation between extensive use of central nervous system acting drugs and adverse reactions such as falls, fractures and mortality (Gogol et al, 2014). reviewed falls risk in relation to medication in older people who had been admitted to hospital. They found that the falls risk was ten times higher in patients who were receiving central nervous system acting drugs.
  4. More than . These can make a real difference to a person’s quality of life but such treatment is not without risk. NSAIDs increase the risks of gastric bleeding. They should not be prescribed with anti-coagulants as this increases bleeding risk. in older patients can be a recipe for disaster as this can affect renal perfusion and renal dysfunction and cause renal impairment. If they are used a proton-pump inhibitor (PPI) should be prescribed to reduce the risks of ulceration (Patient Plus, 2015). They can worsen heart failure and are contraindicated in patients with severe heart failure (EMA, 2015).   NSAIDS increase the risks of heart problems. A large study examined 353,000 patient records from 639 separate clinical trials to assess the impact of NSAIDS. They looked at the risk of heart problems in people taking 150mg diclofenac or 2,400mg ibuprofen each day. Two thirds of NSAID prescriptions are for ibuprofen or diclofenac. They showed that for every 1,000 people taking the drugs there would be three additional heart attacks, four more cases of heart failure and one death every year. The risks are greater in people who are overweight, smoke or are at high risk of heart disease (.Coxib and traditional NSAID Trialists (CNT) Collaboration,2013). Naproxen another NSAID has lower cardiac risks than ibuprofen or diclofenac and is now being prescribed more frequently in an effort to reduce these risks. Naproxen unfortunately causes more gastric irritation that diclofenac or ibuprofen. Some people however may find diclofenac or ibuprofen is most effective and can make an informed choice about treatment risks.   NSAIDs are nephrotoxic and should be used with great caution in those with renal impairment (Curiel &amp; Katz, 2013).   Use NSAIDS only after careful evaluation of individual risk factors, in the smallest possible dose for the shortest possible time and monitor carefully.
  5.  
  6.   and age related changes to the renal and hepatic system mean that the older person is at greater risk of toxicity. When opiates are clinically required they should be started at doses 25-50% lower than in younger patients (Chau et al, 2008).